On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hôpital de la Timone

InstitutionResearch output, impact & collaborations

Hôpital de la Timone is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hôpital de la Timone?

ScholarIQrecord summary

Hôpital de la Timone is a research organisation in Marseille, FR. OpenAlex records 21,011 works and 1,632,230 citations for it. 4,131 researchers list it as their most recent affiliation.

How many works does Hôpital de la Timone have?

ScholarIQindexed works

Hôpital de la Timone has 21,011 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hôpital de la Timone have?

ScholarIQcitation count

Hôpital de la Timone has 1,632,230 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hôpital de la Timone?

ScholarIQresearcher count

Hôpital de la Timone has 4,131 researchers in the ScholarIQ index.

What is the average h-index at Hôpital de la Timone?

ScholarIQavg h-index

Hôpital de la Timone has an average h-index of 57 in OpenAlex.

What is the ROR of Hôpital de la Timone?

ScholarIQror

The ROR for Hôpital de la Timone is on the source record.

What is the OpenAlex record for Hôpital de la Timone?

ScholarIQopenalex

The OpenAlex for Hôpital de la Timone is on the source record.

Who are the most-cited researchers behind Hôpital de la Timone?

ScholarIQtop researchers by citations
1
Gilbert Habib · Infective Endocarditis Diagnosis and Management
719 works61,098 citations
2
Olivier Chinot · Glioma Diagnosis and Treatment
594 works25,951 citations
3
Gilbert Habib · Cardiac Valve Diseases and Treatments
19 works17,153 citations
4
Jean‐François Seitz · Colorectal Cancer Treatments and Studies
228 works16,807 citations

What are the most-cited papers on Hôpital de la Timone?

ScholarIQmost cited works
2015 ESC Guidelines for the management of infective endocarditis
Gilbert Habib, Patrizio Lancellotti, Manuel J. Antunes, Maria Grazia Bongiorni, Jean‐Paul Casalta, Francesco Del Zotti, Raluca Dulgheru, Gébrine El Khoury, Paola Anna Erba, Bernard Iung, José M. Miró, Barbara J.M. Mulder, Edyta Płońska‐Gościniak, Susanna Price, Jolien W. Roos‐Hesselink, Ulrika Snygg‐Martin, Franck Thuny, Pilar Tornos Mas, Isidre Vilacosta, José Luis Zamorano
European Heart Journal. 20155,003 CitationsOPEN ACCESS
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Authors Task Force Members, Alec Vahanian, Helmut Baumgartner, Jeroen J. Bax, Eric G. Butchart, Robert Dion, Gerasimos Filippatos, Frank A. Flachskampf, R. Hall, Bernard Iung, Jarosław D. Kasprzak, Patrick Nataf, Pilar Tornos, Lucia Torracca, Arnold C. G. Wenink, Silvia G. Priori, J J Blanc, Andrzej Budaj, A. John Camm, V. Dean, Jaap W. Deckers, Kenneth Dickstein, J. Lekakis, K. McGregor, Marco Metra, João Morais, A. Osterspey, J. Tamargo, J. L. Zamorano, Document Reviewers, J. L. Zamorano, Annalisa Angelini, Manuel J. Antunes, Margaret Fernandez, Christa Gohlke-Baerwolf, Gilbert Habib, John J.V. McMurray, Catherine M Otto, Luc Piérard, José L. Pomar, Bernard Prendergast, Raphaël Rosenhek, M. S. Uva, J. Tamargo
European Heart Journal. 20063,595 CitationsOPEN ACCESS
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia, Herbert I. Hurwitz, Alan B. Sandler, David Miles, Robert L. Coleman, Regula Deurloo, Olivier Chinot
Cancer Treatment Reviews. 20201,153 Citations
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valérie Vilgrain, Héléna Pereira, Eric Assenat, Boris Guiu, Alina Diana Ilonca, Georges-Philippe Pageaux, Annie Sibert, Mohamed Bouattour, Rachida Lebtahi, Wassim Allaham, Hélène Barraud, Valérie Laurent, E. Mathias, Jean-Pierre Bronowicki, J.P. Tasu, R. Perdrisot, Christine Silvain, René Gerolami, O. Mundler, Jean‐François Seitz, Vincent Vidal, Christophe Aubé, Frédéric Oberti, Olivier Couturier, Isabelle Brenot-Rossi, Jean‐Luc Raoul, Anthony Sarran, Charlotte Costentin, Emmanuel Itti, Alain Luciani, René Adam, M. Lewin, Didier Samuel, Maxime Ronot, Aurélia Dinut, Laurent Castéra, Gilles Châtellier, Eric Assenat, Elisabeth Delhom - Christol, Boris Guiu, Alina Diana Ilonca, J. Lonjon, Georges-Philippe Pageaux, Mohamed Abdel‐Rehim, Wassim Allaham, Mohamed Bouattour, Laurent Castéra, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Valérie Vilgrain, Hélène Barraud, Christophe Bazin, Jean-Pierre Bronowicki, Valérie Laurent, E. Mathias, Carine Chagneau-Derrode, R. Perdrisot, Christine Silvain, J.P. Tasu, Patrick Borentain, René Gerolami, O. Mundler, Jean‐François Seitz, Vincent Vidal, Christophe Aubé, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Jean‐Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, René Adam, M. Lewin, Didier Samuel, Julien Edeline, Étienne Garin, Yan Rolland, Isabelle Archambeaud, Thomas Eugène, Éric Frampas, Christophe Cassinotto, Martine Guyot, Jean‐Baptiste Hiriart, Bruno Lapuyade, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, François Habersetzer, Alessio Impériale, Philippe Merle
The Lancet Oncology. 2017831 Citations
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, Guy de La Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, Béata Juzyna, Thierry Conroy
Journal of Clinical Oncology. 2012434 CitationsOPEN ACCESS

How much of the research on Hôpital de la Timone is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
8%
Green
0%
Hybrid
0%
Bronze
75%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial